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Abstract
The medial ganglionic eminence (MGE) is an embryonic forebrain structure that generates the majority of cortical
interneurons. MGE transplantation into specific regions of the postnatal central nervous system modifies circuit function
and improves deficits in mouse models of epilepsy, Parkinson’s disease, pain, and phencyclidine-induced cognitive deficits.
Herein, we describe approaches to generate MGE-like progenitor cells from mouse embryonic stem (ES) cells. Using a
modified embryoid body method, we provided gene expression evidence that mouse ES-derived Lhx6+ cells closely
resemble immature interneurons generated from authentic MGE-derived Lhx6+ cells. We hypothesized that enhancers that
are active in the mouse MGE would be useful tools in detecting when ES cells differentiate into MGE cells. Here we
demonstrate the utility of enhancer elements [422 (DlxI12b), Lhx6, 692, 1056, and 1538] as tools to mark MGE-like cells in ES
cell differentiation experiments. We found that enhancers DlxI12b, 692, and 1538 are active in Lhx6-GFP+ cells, while
enhancer 1056 is active in Olig2+ cells. These data demonstrate unique techniques to follow and purify MGE-like derivatives
from ES cells, including GABAergic cortical interneurons and oligodendrocytes, for use in stem cell-based therapeutic assays
and treatments.
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Introduction
Cortical interneuron dysfunction may contribute to the risk of
developing autism, epilepsy, bipolar disorder, schizophrenia, and
dementia [1,2,3,4,5]. Cortical interneurons are born in the
progenitor zones of the medial ganglionic eminence (MGE), the
caudal ganglionic eminence (CGE) and preoptic area (POA), and
migrate tangentially into the cortex [6,7,8] (abbreviations are listed
in Table S1 in File S2). Several transcription factors, such as
Dlx1&2, Nkx2-1 and Lhx6, regulate interneuron development. For
instance, Dlx1&2 are required for interneuron migration to the
cortex [6,9,10,11,12,13]. Dlx12/2mice are viable, but, due to late-
onset interneuron loss, develop cortical dysrhythmias and epilepsy
[9]. Nkx2-1 specifies MGE identity; in Nkx2-1 null mice the MGE
acquires lateral ganglionic eminence (LGE)/CGE identity and
lacks MGE-derived interneurons, in part because they fail to
express Lhx6 [14,15,16,17]. In turn, Lhx6 is required for
differentiation of Parvalbumin+ and Somatostatin+ interneurons
[18,19].
Heterochronic transplantation of rodent embryonic MGE cells
into neonatal cortex or adult hippocampus results in their efficient
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dispersion and integration within host circuits [20,21,22,23].
Furthermore, studies have demonstrated a therapeutic proof of
concept that transplantation of MGE cells into rodent models of
neuropsychiatric or neurological disorders can suppress seizures,
reduce injury induced neuropathic pain, ameliorate phencycli-
dine-induced cognitive deficits and partially rescue Parkinsonian
symptoms [22,23,24,25,26,27,28,29].
While fetal MGE is a potential source for human transplanta-
tion, generating MGE cells from stem cells is advantageous due to
limited availability and ethical issues surrounding the use of fetal
tissue. Thus, several groups have embarked on generating MGE
cells from embryonic stem (ES) cells [30,31].
Subsequently, mouse and human ES cells lines were generated
expressing GFP under the control of loci that mark MGE cells.
The J14 mouse ES cell line expresses GFP from an Lhx6 bacterial
artificial chromosome (BAC) transgene and can differentiate into
mature Lhx6-GFP+ cortical interneurons after transplantation
[32]. Human NKX2-1GFP/w ES cells express GFP from the
endogenous NKX2-1 locus and were shown to differentiate into
NKX2-1-GFP+ basal forebrain progenitors that further differen-
tiated into GABA+ and TH+ neurons, and PDGFRa+ oligoden-
drocytes [33]. We hypothesize that small enhancer elements active
in the mouse MGE will be useful in detecting when ES cells
differentiate into MGE cells. Thus, we describe our alternative
approach to label specific stages of stem cell differentiation using
four small enhancer elements that drive expression in a highly
restricted repertoire of cell states related to the MGE and its
derivatives.
Materials and Methods
Ethics Statement
All animals were treated in accordance with the protocols
approved by the Institutional Animal Care and Use committee
(IACUC) at University of California, San Francisco (UCSF
approval number: AN083918-03A; Approval Date: August 29,
2012; Expiration Date: July 26, 2013). In all the animal
experiments, animals of either sex were used.
ES cells maintenance and differentiation
Mouse Foxg1::venus [30] and E14 embryonic stem (ES) (a kind
gift from Jeremy Reiter, UCSF; from Bay Genomics) cells
maintenance medium was GMEM medium supplemented with
10% Knock Out Serum Replacement (KSR) (Invitrogen), 1%
Fetal Bovine Serum (Hyclone, Define Serum), 1 mM sodium
pyruvate (Sigma), 0.1 mM MEM nonessential amino acids
(NEAA, Invitrogen), 0.1 mM 2-ME (2-mercaptoethanol, Sigma,
freshly prepared each time). For J14 cells [32], maintenance
medium was Knockout DMEM (Invitrogen) supplemented with
15% FBS, 2 mM glutamate (UCSF Cell Culture Facility), 0.1 mM
NEAA, 1X Pen/Strep (UCSF Cell Culture Facility), 0.1 mM 2-
ME. In all ES cells, 2000 U/ml Leukaemic Inhibitory Factor (LIF,
Millipore) was added freshly every other day. For feeder cells (SNL
and SNLB, see below in the section of Generation of
lentivirus-transduced ES cell clones) media: DMEM with
10% FBS with glutamate and 1X Pen/Strep. For all ES cell
differentiation media: GMEM medium supplemented with 10%
KSR, 1 mM sodium pyruvate, 0.1 mM NEAA, 0.1 mM 2-ME;
different lots of KSR produced different percentage of Lhx6-GFP+
cells (and Foxg1::venus+ cells) and therefore required testing for
inclusion in the differentiation media. For improved "serum-free
embryoid body-like" (SFEBq) culture (see Results, modified from
the study of [34]), ES cells were dissociated into single cells with
0.25% trypsin-EDTA (Invitrogen) and quickly re-aggregated in
the differentiation media containing 100 ng/ml Dickkopf-1(Dkk-1)
(5000 cells/100 ml/well) using 96-well low cell adhesion plates
(Lipidure-coat plate A-U96, NOF America). On day 3 of
differentiation (D3), 20 ml of differentiation media containing
SAG (Alexis Biochemicals) was added into each well so that the
final concentration of SAG was 6 nM. On D6, ES cell aggregates
(embryoid body (EB) aggregates) were transferred to a 10-cm
bacterial-grade dish with DMEM/F12 (Invitrogen) supplemented
with N2 (Invitrogen) and 6 nM SAG.
Immunohistochemistry
ES EB aggregates at various time points of differentiation were
collected and fixed with 4% paraformaldehyde, then cryopro-
tected with 15% sucrose overnight before embedding in optimal
cutting temperature (O.C.T.; Tissue-Tek, Sakura Finetek) media.
Each aggregate was frozen and cryostat sectioned into 30610 mm
sections for immunofluorescent analyses. For antibody staining,
glass slides with sections were washed with PBS three times and
permeabilized with 0.3% Triton X-100 before blocking with 2%
skim milk (Difco). Primary antibodies were, chicken anti-GFP
(1:500, Aves Labs), rabbit anti-Ds-Red (for mCherry staining)
(1:500, Clontech), rat anti-Ds-Red (1:500, ChromoTeK), mouse
anti-Nkx2-1 (1:200, Leica microsystems), rabbit anti-Nkx2-1
(1:200, Santa Cruz Biotechnology, Inc.), guinea pig anti-Dlx2
(1:2000, kindly provided by Kazuaki Yoshikawa, Osaka Univer-
sity, Osaka, Japan) [35], rabbit anti-Foxg1 (1:2000) [31], mouse
anti-Islet1 (1:250, IOWA Hybridoma Bank), mouse anti-human
Ki67 (1:200, BD Pharmingen), rabbit anti-Tbr1 (1:1000, Milli-
pore), rabbit anti-Olig2 (1:500, Millipore), mouse anti-Mash1
(1:500, BD Pharmingen), rabbit anti-GABA (1:1000, Sigma),
rabbit anti-Calbindin (1:2000, Swant), rabbit anti-Mafb (1:1000,
Bethyl Laboratories), rabbit anti-PV (1:2000, Swant), rat anti-Sst
(1:250, Millipore), goat anti-Sst (1:200, Santa Cruz Biotechnology,
Inc.), rabbit anti-NPY (1:250, ImmunoStar), mouse anti-b-III-
Tubulin (TUBIII) (1:1000, TUJ1, Covance). Alexa 488 and Alexa
594 secondary antibodies (1:500, Invitrogen) were used according
to the primary antibody species. Sections were counterstained with
49, 6-diamidino-2-phenylindole (DAPI, 5 ng/ml, Invitrogen).
Image analyses
Immunofluorescent images were taken using a Nikon Eclipse
80i microscope (Nikon), a CoolSnap camera (Photometrics), and
NIS Elements BR 3.00 software (Nikon). For marker co-
localization, we used image J for cell counting in the red, green
and red+green channels. Counting was performed on 2006
magnification images. At least three images were counted to
obtain mean6 SEM. The degree of differentiation inside each EB
aggregate is different; thus we performed our quantification on
those EBs with high expression of GFP and Nkx2-1.
For co-localization of various markers with Lhx6-GFP+,
DlxI12b-bg-mCherry+, 692-mCherry+ (692-bg-mCherry+) and
1056- bg-mCherry+ cells we wrote a Macro (set of instructions)
in Image J to perform automated cell counting using each color
channel (red and green) and the red/green co-localized channel.
The threshold was set at 81–255 for the green channel, and 69–
255 for the red channel; then the Macro was set to ‘‘convert to
mask’’, ‘‘watershed’’, and ‘‘analyze particle size = 15–200; circu-
larity = 0.20–1.000 for the individual color and combined color
channels. For the co-localized channel the Macro was set to:
‘‘colocalization’’, "channel1 = red; channel2 = green, ratio = 50,
threshold channel 1= 50, threshold channel 2 = 50, display = 255,
co-localized’’ (see Results section for the results of the automated
cell counting).
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For co-localization of 692-mCherry+, 692-bg-mCherry+ cells
with Lhx6-GFP+, we manually counted cells from images taken
from immunofluorescent staining (the data was comparable to that
done by Image J analyses but included more in depth analyses).
GFP+ and mCherry+ cells were counted according to its expression
level as bright cells or dim cells (there were 3–10 times more of dim
mCherry+ cells than bright mCherry+ cells, whereas there were
usually 2–3 times more of bright GFP+ cells than dim GFP+ cells).
The percentage of co-localization in the result sections considered
all cells. From one of the clones from each construct (J6M1 and
J6bM31) we also calculated the percentage of co-localization
among bright GFP+ and mCherry+ cells. In summary,
92.94%69.85% of 692-mCherry+ cells were Lhx6-GFP+;
88.09%64.7% of 692-bg-mCherry+ cells were Lhx6-GFP+;
among Lhx6-GFP+ cells, 35.44%69.22% were 692-mCherry+
and 31.05%63.59% were 692-bg-mCherry+.
For co-localization of 1538-bg-mCherry+ cells with Lhx6-GFP+,
we manually counted cells from 6 images taken from immuno-
fluorescent staining on D14 (see Results section).
Transplantation
On D12 (day 12 of differentiation), ES EB aggregates from 20
96-wells plates were collected (1920 aggregates) and dissociated
with the enzyme solution of the Neural Tissue Dissociation Kit
(Sumitomo Bakelite, MB-X9901) [34]. Rock inhibitor Y-27632
(10 mM) was added in all the solutions to prevent cell death. Cells
were stained with Sytox Blue (Invitrogen, to eliminate dead cells)
in 1% BSA/HBSS 15 minutes before sorting to distinguish dead
vs. live cells. Lhx6-GFP+ cells were sorted with BD FACSAria II
using 100 mm nozzle and collected in 10% FBS/DMEM/F-12.
Fifty to one hundred thousand sorted ES-Lhx6-GFP+ cells were
microinjected into the cortex of P0–P2 anesthetized CD-1 mice
(iced for 3 min) using pulled capillary glass pipettes. To anesthetize
young pups, mice were placed on the ice for 3 minutes. For each
experiment, 5–12 animals were injected depending on the cells
collected on that day and the pups born in one litter. Cells were
transplanted into three sites in each hemisphere at a depth of
,1 mm from the surface of skull. The pups were then warmed at
37uC on a warm plate before being returned to the dam. After
transplantation (4 days, 1 month, or 2 months), the mice were
deeply anesthetized (in a CO2 chamber) and then perfused
transcardially with 4% paraformaldehyde, post-fixed in 4%
paraformaldehyde overnight, and cryo-protected in 30% su-
crose/PBS overnight before frozen in the optimal cutting
temperature (O.C.T.; Tissue-Tek, Sakura Finetek) compound.
Fifty mm brain cryo-sections were obtained with cryostat for
immunostaining.
RNA microarray analyses
RNA was isolated from fluorescent activated cell sorting (FACS)
purified ES-Lhx6-GFP+, ES-Lhx6-GFP2, and MGE-Lhx6-GFP+
cells using RNeasy Micro kit (QIAGEN) according manufacturer’s
instructions. The procedures of EB aggregates dissociation, FACS
purification and collection of cells were the same as described
above for cell transplantation. Embryonic 12.5 (E12.5) MGE from
Lhx6-GFP transgenic mouse (in CD-1 background) brains were
dissected and dissociated into single cells with 0.05% Trypsin/
EDTA (UCSF CCF) with 10 mg/ml DNase I (Roche) at 37uC for
15 min. Purified total RNA was submitted to the Genomic Core at
UCSF (http://www.arrays.ucsf.edu), for quality assessment using a
RNA Pico Chip on an Agilent 2100 Bioanalyzer (Agilent
Technologies). Total RNA was amplified using the Sigma whole
transcriptome amplification kits following the manufacturer’s
protocol (Sigma) and Cy3-CTP labeled with NimbleGen one-
color labeling kits (Roche-NimbleGen Inc). Equal amounts of Cy3
labeled targets were hybridized to Agilent whole mouse genome
8660 K Ink-jet arrays. The data was extracted with Feature
Extraction v10.1 software (Agilent).
Genome coordinates of enhancers
Enhancer 422 is located between Dlx1 and Dlx2 genes (human:
chr2:172,955,879–172,957,052[hg19]; corresponding to mouse:
chr2:71,373,435–71,374,614[mm9]), and encompasses the Dlx1
and Dlx2 intragenic enhancer, DlxI12b, (mouse: chr2:71,374,047–
71,374,552[mm9]) [36,37]. Enhancer 692 is located on human
chromosome 11 (chr11:15,587,041–15,588,314[hg19]) near Sox6
gene. Enhancer 1056 is on human chromosome 18 (human
coordinates: chr18:76,481,720–76,483,257[hg19]) near Sall3 gene.
Enhancer 1538 is on human chromosome 14 (ch14: 36,911,162–
36,914,360[hg19]) near Nkx2-1 gene. The 2.1 kb mouse Lhx6
enhancer with proximal promoter was described by Du et al.,
2008; it extends from the 5’ non-coding sequence through the end
of intron 1 of Lhx6 gene.
Transgenic mouse enhancer assay
Enhancer candidates were amplified by polymerase chain
reaction (PCR) from human genomic DNA (Clontech) and cloned
into the Hsp68 promoter-b-galactosidase (LacZ) reporter vector as
previously described [38]. Transgenic mouse embryos were
generated by pronuclear injection and F0 embryos were collected
at E11.5 and stained for b-galactosidase (b-gal) activity with 5-
bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal). Since a
sufficient number of embryos expressed LacZ (had b-gal blue
staining in some structures) were obtained, no PCR genotyping
was done. We used "blue in any structure" as the transgenic count,
and the proportion of embryos with forebrain staining (as assessed
from the whole-mount) as a measure of reproducibility. Only
patterns that were observed in at least three different embryos
resulting from independent transgenic integration events of the
same construct were considered reproducible. Here are the
numbers for each enhancer. In all cases, the [x/y/z] numbers
below indicate E11.5 embryos with staining in that feature/the
total number of blue embryos (embryos with blue staining in at
least some structures, regardless of the pattern)/the total numbers
of embryos that were collected at E11.5. Enhancer 422: midbrain
(mesencephalon) [7/7/38]; forebrain [6/7/38]; nose [6/7/38].
Enhancer 692: forebrain [9/9/83]. Enhancer 1056: neural tube
[5/8/40]; midbrain [5/8/40]; forebrain [7/8/40]. Enhancer
1538: forebrain [4/4/34]. In summary, all of the enhancers
exhibited greater than 80% of consistent patterns in transgenic
mouse enhancer assay. For detailed section analyses, embryos
collected at E11.5 were fixed in 4% paraformaldehyde and stained
with X-Gal overnight. X-Gal–stained embryos were then embed-
ded in paraffin using standard methods. Coronal sections of the
head were cut using standard methods, counterstained with Eosin
for visualization of X-Gal -negative embryonic structures and
photographed.
Lentiviral vector generation
The DlxI12b DNA fragment was PCR amplified from the
DlxI12b-bglobin-Cre vector [37] with introduced 59 BamHI and
39 AgeI sites in the primers: (forward: 59-CTCTGGATCCACA-
CAGCTTAATGATTATC-39, reverse: 59-GAGAACCGGTG-
CAGGAATTCATCGATGATA-39). The 692, 1056 and 1538
DNA fragments were PCR amplified from human genomic DNA
(Roche) with introduced 59 BamHI and 39 AgeI sites in the
primers: (692 forward: 59-ACAAGGATCCCACATCT-
CAGTGGCTCAT-39, reverse: 59-TCTAACCGGT-
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CAGGGTGTCTGTGTTGATG-39), (1056 forward: 59-GA-
CAGGATCCGTCCCTCACAGAACTCAG-39, reverse: 59-GA-
CAACCGGTGATGCCTGCCTTGAAGTC-39), (1538 forward:
59-TCTAGGATCCTGCTGCCTCAAACAAGAATG-39, re-
verse: 59-AGTTACCGGTTTGGATGAGGGAAAGACCTG-
39). Digested DNA fragments of enhancers were cloned into the
BamHI and AgeI sites of the pLenti-mcs-mCherry_Rex1-Blasticidinr
vector [39]. The b-globin minimal promoter (template: DlxI12b-b-
globin-Cre) and the hsp68 minimal promoter [40] were PCR
amplified with the following primers: (b-globin forward: 59-
CTATACCGGTAGCCCGGGCTGGGCATAA-39, reverse: 59-
GAGAACCGGTCGCCGCGCTCTGCTTCTGG-39), (hsp68
forward: 59-GAGAACCGGTGCATCGGCGCGCCGACC-39,
reverse: 59-ATATTCCGGAGGCGCCGCGCTCTGCTTC-39).
See Table S10 in File S2 for full list of primers. The minimal
promoters were inserted into the AgeI site that preceded the
mCherry gene. The Dlx-I12b-b-globin fragment was PCR amplified
directly from [37], using the Dlx-I12b forward and b-globin reverse
primers described above. All of the primer sequences are in Table
S10 in File S2. All PCR fragments and lentiviral constructs were
verified by restriction enzyme digests and DNA sequencing.
Lentivirus production
HEK293T cells (a gift from Daniel Lim, UCSF; from Thermo
Scientific) grown in DMEM with 10% FBS were transfected using
Fugene 6 transfection reagent (Roche) with four plasmids to
generate lentivirus particles. Plasmids used for a 10 cm tissue
culture plate of HEK293T cells (at about 50–70% confluence):
6.4 mg of lentiviral vector DNA and 1.2 mg each of 3 helper
plasmids (pVSV-g, pRSVr and pMDLg-pRRE). Media was complete-
ly replaced 4 hours after transfection, and cells were grown for
four days before harvesting. On day four, all the media was
collected and filtered through a 0.45 low protein binding
membrane to remove cells and large debris. Filtered media was
either aliquoted then stored at 280uC (unconcentrated), or pooled
and ultracentrifuged at 100,0006 g for 2.5 hours at 4uC. The
concentrated viral pellet was resuspended overnight in sterile PBS
(adding 50 ml of PBS to the pellet for each 10 cm plate used), then
stored at 280uC.
Generation of lentivirus-transduced ES cell clones
To generate ES cell clones containing lentiviral constructs,
proliferating cells (E14 or J14) were dissociated and 400,000 cells
were incubated with concentrated virus in a 1.5-ml microcen-
trifuge tube at 37uC for 1 hour (mixing every 15 min). The cells/
virus were then transferred into ES maintenance media containing
LIF for an overnight incubation [E14 cells were seeded onto
gelatin coated plates without feeders; for J14, cells were seeded
onto mitomycin C-treated SNLB feeder cells (see below)]. The
next day, the supernatant/virus was removed and fresh media
with LIF was supplied for another day before adding blasticidin
(20 mg/ml for E14 cells and 4 mg/ml for J14) for 1 week of
selection (changing media daily or every other day depending on
cell density). Individual colonies emerged ,1 week after virus
infection and were picked up by blunt 10 ml tips, then trypsinized
into one well of a 96-well plates. Each clone was expanded and
frozen down for further analysis. To establish blasticidin-resistant
feeder cells SNLB, an STO cell line (SNL76/7, a kind gift from
Louis Reichardt, UCSF; from ATCC) that expresses a Neomycin
resistance gene and a LIF gene, was transfected with pcDNA6/V5-
His ABC plasmid (Invitrogen, empty vector with Blasticidin resistance
gene driven by EM7). Mixed colonies of blasticidin-resistant SNLB
cells were expanded for frozen aliquots, or treated with mitomycin
C for J14 enhancer cell line selection and maintenance.
Results
Dissociated MGE cells cultured in vitro lose Lhx6-GFP
expression
We first attempted to expand MGE progenitors directly from
dissociated embryonic mouse MGE tissue. Since previous studies
had been successful in expanding neural stem cells in serum-free or
serum-containing media with the addition of epidermal growth
factor (EGF) and basic fibroblast growth factor (bFGF, or FGF-2)
[41,42], we tested these different protocols for MGE cells. We used
MGE cells dissociated from E12.5/E13.5 transgenic embryos that
expressed b-Galactosidase (b-Gal) or GFP in postmitotic MGE
neurons, including immature cortical interneurons, under the
control of a zebrafish Dlx5/6 enhancer or a mouse Lhx6-GFP BAC
transgene [43,44,45]. Prolonged MGE culture (more than 10 days
in vitro), or passage of cells that involved trypsinization, resulted in a
marked decrease in Nkx2-1 (data not shown) and Lhx6-GFP
expression (See Text T1, Methods M1, M2 and Figure S1 in File
S1). Neonatal cortical transplantation of MGE-derived cells grown
for 21 days in culture resulted in no detectable GFP+ cells in the
adult cortex. Because we were unable to produce stable pools of
Lhx6-GFP+ neurons from MGE primary dissociated cultures, we
concentrated on using embryonic stem cells to generate Lhx6-
GFP+ MGE-like neurons.
Using embryonic stem cells to generate cortical
interneuron precursors
Embryonic stem (ES) cells, grown feeder-free in suspension or as
adherent culture, can be expanded and differentiated into
forebrain progenitors and neurons [31,32,33,46]. The serum-free,
floating culture of embryoid body-like aggregates (‘SFEB’) method
is an efficient approach for converting ES cells into neural stem
cells [31]. In particular, addition of two growth factor inhibitors,
the anti-Wnt reagent Dickkopf-1 (Dkk-1) and the anti-Nodal
reagent Lefty-A (or SB431542), during the early time points of
differentiation efficiently generates Foxg1+ telencephalic neural
stem cells from ES cells [30,31]. An improved serum-free
embryoid body-like (SFEBq) method using low cell-adhesion U-
shape 96-well plates facilitates the aggregation of mouse ES cells
after dissociation, generating aggregates of uniform size during
differentiation and higher efficiency of production of Foxg1+ cells
[30]. To convert neural stem cells into ventral telencephalic cells,
Sonic hedgehog (Shh) recombinant protein or SAG, a small
molecule that binds to Smoothened and activates Shh downstream
pathway, was added on days 3 and 6 (D3 and D6) after
differentiation [34].
We used the SFEBq method (Figure 1A and Figure 2A) to
generate MGE progenitor-like cells with three mouse ES cell lines:
Foxg1::venus [30], E14 (the parental cell line for Foxg1::venus)
and J14 (Lhx6-GFP transgenic line) [32]. We optimized concen-
trations of Dkk-1, Shh, SAG, and other growth factors for MGE-
like cell production based on Nkx2-1, Lhx6-GFP, and/or Foxg1
expression (Figure 1A and Figure S2 in File S1). We found that a
modification of Danjo et al., 2011 [34] (Condition 1 in Figure 1A:
using KSR-based media, adding 100 ng/ml Dkk-1 on day 0, and
adding 6 nM SAG on day 3 and day 6 of differentiation; now
referred to as the ES-MGE differentiation protocol, Figure 1A,
Figure 2A and Figure S2 in File S1) was the best procedure for
generating Lhx6-GFP+ cells from J14 and J14-derived cells (see
below for J14 enhancer cell lines) (Figure 1B-C). In addition SAG
was more efficient and reproducible than recombinant Shh at
generating Nkx2-1+ cells (data not shown). The efficiency of the
ES-MGE differentiation protocol for induction of Lhx6-GFP
expression at D15 (day 15 of differentiation) was ,2-fold greater
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than the protocol of Danjo et al., 2011 [34] (Figure S2A-A9 in File
S1). Among all the protocol tested, ES-MGE differentiation
protocol was most efficient in generating Lhx6-GFP+ and
Foxg1::venus+ cells (Figure S2B-B9 and S2C-C0 in File S1).
On D9 (day 9 of differentiation), the E14 cells expressed
markers of MGE and POA ventricular zone (VZ) and subven-
tricular zone (SVZ) progenitors (such as Nkx2-1, Mash1, and Islet
1; Figure S3A and B in File S1); by D15 (day 15 of differentiation),
there was a reduction of the number of Nkx2-1 expressing cells
Figure 1. Comparison of various conditions for mouse ES cells differentiation using Lhx6-GFP+ cell percentage as a criteria for
optimization. J14-derived ES cell line J6M1 (J14 carrying lentiviral enhancer 692-mCherry) were tested for differentiation using four conditions
listed. (A): In condition 1 and 2 (shown in blue and green), cells were differentiated in GMEM+10% KSR media while in condition 3 and 4 (shown in red
and purple), cells were differentiated in Neurobasal media supplemented with B27 without retinoic acid (NB/B27), a commonly used media for neural
progenitor differentiation [69]. Either 100 or 200 ng/ml Dkk-1 was added on day 0 of differentiation (D0), (B): Among all four conditions, KSR-
containing media surpassed NB/B27 media in the generation of Lhx6-GFP+ cells. Addition of 26more Dkk-1 on D0 did not improve the efficiency of
Lhx6-GFP+ cells with KSR-containing media. (C): FACS analyses of Lhx6-GFP+ cells with Condition 1. The X-axis showed green fluorescent gating with
the log scale.
doi:10.1371/journal.pone.0061956.g001
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(Figure S3A9 and B9 in File S1), suggesting a reduction in MGE
and POA-type progenitors. On the other hand, between D9–D15,
there was an increase in cells expressing GABA and Calbindin,
markers of MGE and POA-type neurons (Figure S3C–D9 in File
S1). To obtain better evidence for MGE neuronal differentiation
we needed more specific markers for this cell type, and therefore
turned to the J14 ES cell line.
MGE progenitor cells give rise to Lhx6+ cortical interneurons,
striatal interneurons, and globus pallidus neurons [47,48,49]. To
examine if Lhx6 was expressed in our ES-MGE differentiation
protocol, we studied GFP expression in J14 cells. Using the SFEBq
method with our ES-MGE differentiation protocol, we found that
Lhx6-GFP+ cells began to emerge on D9–10 of differentiation,
when there was robust induction of Nkx2-1 expression (Figure 2B-
B0). The number of Lhx6-GFP+ cells peaked on D12–13
(Figure 2C9) with a slight decline on D15–16 (Figure 2E9). By
contrast, the number of Nkx2-1+ cells peaked on D9–D10 and
gradually decreased from D12 to D16 (Figure 2B–E). We
measured the fraction of Nkx2-1+ cells that expressed Lhx6-GFP
by immunofluorescence. On D10, about 50% of Nkx2-1+ cells
were Lhx6-GFP+ (mean 6 SEM: 48.963.8%, n= 3), whereas
70% of Lhx6-GFP+ cells were Nkx2-1+ (72.1615.0%). On D12,
75% of Nkx2-1+ cells were Lhx6-GFP+ (75.3612.9%), and 63% of
Lhx6-GFP+ cells were Nkx2-1+ (62.966.0%, n= 3). By D14 and
D16, the percentage of Nkx2-1 and Lhx6-GFP co-expression
decreased; only 43.361.9% and 42.865.2% of Nkx2-1+ cells were
Lhx6-GFP+, and 34.761.8% and 47.3613.8% of Lhx6-GFP+
cells were Nkx2-1+ on D14 and D16 respectively (n = 3). Thus, by
using an optimized SFEBq method (our ES-MGE differentiation
protocol), J14 and E14 ES cells can be differentiated into MGE-
like Nkx2-1+ progenitors and Lhx6-GFP+ neurons.
Comparison of RNA expression profiles between ES-
Lhx6-GFP+ cells and ES-Lhx6-GFP2 cells generated from
mouse J14 ES cells
To further define the molecular properties of the Lhx6-GFP+
cells, we used RNA expression array to investigate molecular
properties of Lhx6-GFP+ (ES-Lhx6-GFP+) cells generated from
J14 cells at D12 of the ES-MGE differentiation protocol. ES-Lhx6-
GFP+ cells and ES-Lhx6-GFP2 cells (both from D12 EB
aggregates) were isolated by fluorescent activated cell sorting
(FACS) and were subjected to RNA expression microarray
analyses (Figure 3, Tables 1; Table S2 and Table S6 in File S2).
Compared to ES-Lhx6-GFP2 cells, the ES-Lhx6-GFP+ cells had
lower expression of neural progenitor markers such as the HES
genes (HES5 in Table 1 and HES1 in Table S2 in File S2),
suggesting that the ES-Lhx6-GFP2 cells were in a more
proliferative state. Consistently, the expression level of the
proliferation marker Mki67 (recognized by the Ki67antibody)
was lower in ES-Lhx6-GFP+ cells (Table S6 in File S2). Subpallial-
specific genes Dlx1, Dlx2, Dlx5, Dlx6, GAD1 (GAD67) and GAD2
(GAD65) were present at higher levels in the ES-Lhx6-GFP+ cells,
consistent with its ventral telencephalic identity (Table 1; Table S2
in File S2). There were also higher mRNA expression of Nkx2-1,
Lhx6, Lhx8 and Sox6 (Table 1) in the ES-Lhx6-GFP+ cells,
consistent with MGE identity. Markers present in migrating
immature interneurons such as ErbB4, MafB, Npas1, Sst (Somato-
statin) (Table 1), NPY (Neuropeptide Y) and Calb1 (Calbindin) (Table S2
in File S2) were also expressed at higher levels in ES-Lhx6-GFP+
cells. In contrast, genes expressed in oligodendrocyte precursors
and oligodendrocytes, such as Olig2 and Sox10, were expressed at
higher levels in the ES-Lhx6-GFP2 cells (Table 1; Table S2 in File
S2). There was also higher expression of pallial markers (Pax6,
Tbr1, Tbr2 and Neurod1) and LGE (striatal) markers (Ebf1 and
FoxP1) in the ES-Lhx6-GFP2 cells (Table 1; Table S2 in File S2).
We also examined hypothalamic and retinal marker expression
by microarray analyses. Rax (Rx) expression was higher in the ES-
Lhx6-GFP+ cells than in the ES-Lhx6-GFP2 cells (Table 1),
suggesting that some of these cells have either hypothalamic or
retinal properties as Rax is essential for early retinal and
hypothalamic development [50,51,52]. On the other hand,
Nkx2-2 expression was lower in the ES-Lhx6-GFP+ cells
compared to the ES-Lhx6-GFP2 cells (Table 1). Nkx2-2 is a
marker of the hypothalamus and not the early retina [53,54],
although at mature stages it is expressed in retinal glia [55].
Finally, Otp (a marker of paraventricular nucleus anlage) [50,56] is
expressed near background levels in all three samples (Table 1).
Since Lhx6 is expressed in a small domain of the caudoventral
hypothalamus (Allen Brain Atlas), it is possible that some of the ES
Lhx6-GFP+ cells differentiated towards a hypothalamic fate.
To confirm these data, we analyzed protein expression with
immunostaining on ES embryoid body (EB) aggregates collected
9–16 days after differentiation (D9–D16) (Fig. 2F–K and Figure
S4–S9 in File S1). Consistent with our microarray data, ,50% of
the Lhx6-GFP+ cells co-expressed Dlx2 and ,75% of the Lhx6-
GFP+ cells co-expressed Foxg1 at D12 (Figure 2F and G), few
Lhx6-GFP+ cells expressed Islet1 (Figure 2H), and none co-
expressed Mki67, Tbr1 or Olig2 (Figure 2I–J) on D11–D13. Thus
the RNA expression array and immunostaining result provide
strong evidence that Lhx6-GFP+ cells from J14 ES cells resemble
MGE-derived neurons.
Comparing RNA expression profiles between Lhx6-GFP+
MGE cells and ES-derived Lhx6-GFP+ cells
To further investigate how closely ES cells-derived Lhx6-GFP+
cells resembled authentic Lhx6+ MGE cells, we compared their
gene expression profiles. We used fluorescent activated cell sorting
(FACS) to purify GFP+ cells from the E12.5 MGE of Lhx6-GFP
transgenic mice, and from J14 differentiated ES cells at D12 (see
above). RNA was isolated from the cells and analyzed by gene
Figure 2. MGE differentiation protocol from mouse ES cells (ES-MGE) and characterization of MGE-like differentiated J14 (Lhx6-
GFP) cells. (A): Schema outlining the ES-MGE differentiation protocol. The black horizontal line: time line of days after initiation of differentiation.
Days when a treatment was introduced are indicated (see Materials and Methods for details). From day 0 (D0) to day 6 (D6), cells were cultured with
GMEM and 10% KSR (shown in purple) in a lipidure-coated 96-well plate (shown in cyan). Dkk-1 (100 ng/ml) was added on D0 and SAG (6 nM) was
added on D3 shown in red. On D6, cell aggregates were collected and transferred to a bacterial grade sterile petri dish in DMEM/F-12 supplemented
with N2. Additional SAG (6 nM) was added to the medium on D6. Starting on D9 (and the following days), aggregates were collected either for
immunofluorescent staining, FACS analysis, or FACS purification followed by gene expression microarray analysis, or transplantation. (B–E0): Nkx2-1
expression is shown in red; Lhx6-GFP expression is shown in green; DAPI stains the nucleus blue. B-B0: D10; C-C0: D12; D-D0: D14; E-E0: D16. White
arrows indicate cells co-expressing Nkx2-1 and Lhx6-GFP. (F): Dlx2 (red) and Lhx6-GFP (green) expression on D12. White arrows indicate co-
localization of Dlx2 and Lhx6-GFP. (G): Foxg1 (red) and Lhx6-GFP (green) expression on D12. White arrows indicate co-localization of Foxg1 and Lhx6-
GFP. (H): Islet1 (red) and Lhx6-GFP (green) expression on D12. (I): There were only a few Mki67+ (red) cells that expressed Lhx6-GFP (green) on D11.
(J): No Tbr1+ (red) cells were detected on D12. (K): Olig2+ (red) cells and Lhx6-GFP+ (green) cells were mutually exclusive on D12. Scale bar for all
panels: 100 mm.
doi:10.1371/journal.pone.0061956.g002
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expression array. We focused on the expression levels of genes with
known regulatory functions and/or expression within the
forebrain. We compared expression between the MGE Lhx6-
GFP+ (MGE-GFP+) and J14 Lhx6-GFP+ (ES-GFP+) cells, and
between MGE-GFP+ cells and J14 Lhx6-GFP2(ES-GFP2) cells
(Tables 1; Table S2, Table S7 and Table S8 in File S2). There was
a remarkable similarity in the properties of the MGE-GFP+ and
ES-GFP+ cells (genes shown in bold typed had higher expression
in both MGE-GFP+ and ES-GFP+ compared to ES-GFP2 while
genes underlined had the opposite trends in Table 1). MGE-GFP+
and ES-GFP+ cells both had relatively high expression (.10
arbitrary units) of MGE progenitor markers (Dlx1, Lhx6, Lhx8,
Nkx2-1 and Sox6) and markers of immature MGE-derived pallial
interneurons (ErbB4, GAD1, Lhx6, MafB, Sox6, and Sst). High levels
of Coup-TFI (NR2F1) suggest that the cells have properties of the
dorsal MGE and/or the caudal MGE and CGE.
While MGE-GFP+ and ES-GFP+ cells shared properties of the
MGE and immature cortical interneurons, only the MGE-GFP+
cells showed robust expression of globus pallidus markers (Tables 1;
Table S2 and Table S7 in File S2), including Etv1 (ER81), Gbx2,
Figure 3. Supervised clustering showing all differentially expressed (DE) genes. Microarray comparison of RNA expression from primary
E12.5 MGE Lhx6-GFP+ cells, ES-Lhx6-GFP+ and ES-Lhx6-GFP2 cells. Heatmap includes 1821 probes that exhibit a fold change (FC) of greater than 4 in
any one of the possible 3 pairwise comparisons. Heatmap colors correspond to the signal intensity relative to the global average for that probe. Color
spectrum ranges from red (5) to black (0) to green (-4): red blocks represent sample-specific expression that is elevated relative to the average across
all samples; green blocks represent genes whose transcripts are relatively less abundant. Two areas (A and B, bracketed on the right side) in the
supervised heatmap contain many of the genes that regulate and/or mark developing cortical interneurons (see Tables S2 and S3 in File S2).
doi:10.1371/journal.pone.0061956.g003
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Kctd12, Lhx8 and Zic1 [49] [57]. Furthermore, markers of the
ventricular zone (Hes5), oligodendrocytes (Olig2 and Sox10),
pallium (i.e. cortex; Pax6 and Neurod1), LGE/striatum (Ebf1) and
hypothalamus (Nkx2-2) were expressed lower in both MGE-GFP+
and ES-GFP+ cells than in ES-GFP2 (shown in red in Table S2 in
File S2). Therefore, in vitro D12 differentiated J14-GFP+ cells
exhibit an expression profile similar to immature MGE-derived
interneurons, but do not resemble MGE-derived projection
neurons (i.e. globus pallidus) or other MGE-derived cells such as
oligodendrocytes.
We generated a supervised heatmap (Figure 3; Table S9 in File
S2) and an unsupervised clustering (Figure S12 in File S3) to
Table 1. Select marker genes expression from differentiated ES cells (ES Lhx6-GFP+ and ES Lhx6-GFP2) and E12.5 MGE cells (MGE
Lhx6-GFP+) and the comparisons (fold change) of ES Lhx6-GFP+ vs. ES Lhx6-GFP2, MGE Lhx6-GFP+ vs. ES Lhx6-GFP2, and MGE
Lhx6-GFP+ vs. ES Lhx6-GFP+.
1 2 3 4 5 6 7
Areas or cells of interest Expression levels
Comparison
between groups
(fold changes)
Genes of interest ES Lhx6-GFP+ ES Lhx6-GFP2
MGE Lhx6-
GFP+
ES-GFP+ vs ES-
GFP2
MGE-GFP+ vs ES-
GFP2 MGE-GFP+ vs ES-GFP+
Ventricular Zone
Hes5 11.62 13.39 11.72 0.29 0.31 1.07
Oligodendrocytes
Olig2 8.80 11.63 9.59 0.14 0.24 1.73
Pallial
Neurog2 6.46 9.77 6.22 0.10 0.09 0.85
Pax6 6.38 7.65 5.97 0.43 0.33 0.75
Subpallial
Dlx1 14.14 12.14 14.36 4.00 4.67 1.17
GAD1 13.89 11.59 13.28 4.92 3.22 0.65
LGE/striatum
Ebf1 8.67 10.35 8.25 0.31 0.23 0.75
MGE & CGE progenitors
Nkx2-1 11.67 10.09 12.94 2.98 7.20 2.41
NR2F1 (dorsal MGE & CGE) 13.23 12.62 12.71 1.52 1.07 0.70
MGE subpallial neurons &
globus pallidus
Lhx6 13.16 9.20 14.02 15.50 28.20 1.83
Lhx8 11.49 7.55 13.13 15.31 47.56 3.11
Sox6 11.86 9.89 13.21 3.92 10.00 2.55
Globus pallidus
Etv1 (ER81) 7.04 8.51 11.12 0.43 6.75 17.20
MGE interneurons
ErbB4 10.16 8.39 10.13 3.46 3.33 1.01
MafB 11.63 9.68 11.78 3.86 4.28 1.11
Maf (cMaf, vMaf) 9.94 8.22 10.29 3.30 4.19 1.27
Npas1 10.69 7.86 8.31 7.13 1.57 0.22
Sst 14.22 11.79 13.21 5.39 2.69 0.50
Hypothalamus
Nkx2-2 9.24 10.61 6.68 0.44 0.07 0.19
Otp 6.92 7.16 6.84 0.85 0.80 0.95
Rax 9.10 7.21 7.05 3.70 0.89 0.24
Column 1 lists marker genes for specific cell types and regions. Note that many of these are not specific for those cells states, but are recognized as useful markers.
The expression levels in the columns 2–4 represent the averaged normalized log2 intensity for each gene. The numbers in columns 5–7 (the fold change) are ratios of
the average signal intensity (unlogged) of the two groups in comparison.
Genes that are underlined (shown in red in Table S2 in File S2) are enriched in ES Lhx6-GFP2 cells whereas bold-typed genes (shown in green in Table S2 in File S2) are
enriched in both MGE Lhx6-GFP+ and ES Lhx6-GFP+ cells. For most of the genes, the expression in the ES Lhx6-GFP+ cells and MGE Lhx6-GFP+ cells show similar
expression trends, in comparison to ES Lhx6-GFP2 cells. However, there are a few genes (shown in regular font here, and in black in Table S2 in File S2) that don’t follow
this trend.
doi:10.1371/journal.pone.0061956.t001
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compare differences in global mRNA levels. The supervised
heatmap showed that while the MGE Lhx6-GFP+ and ES Lhx6-
GFP+ cells share commonalities (Table 1; Table S2 and Table S7
in File S2) in their RNA expression profiles, they also have
differences. Importantly, both highly expressed genes that are
known to be required for the development of MGE-derived
cortical interneurons, including Arx, Dlx1, Dlx2, Dlx5, ErbB4,
Foxg1, GAD1, Lhx6, Lhx8, Maf, MafB, Mef2C, Nkx2-1, Nrp1,and
Sox6 (in block A and B in the supervised heatmap in Figure 3; these
genes are included in Tables S2 and S3 in File S2). None-the-less,
the fact that the clustering of MGE Lhx6-GFP+ and ES Lhx6-
GFP+ cells differed provide evidence that additional work needs to
be done to increase the fidelity of the differentiation/purification
protocols to obtain MGE-like cells from ES cells. All of the data
from this microarray study was submitted to GEO database as
GSE43508 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc =GSE43508).
Lhx6-GFP+ cells derived from mouse J14 ES cells become
cortical interneurons after transplantation into mouse
neonatal cortices
We next studied the properties of these cells in vivo. Our analyses
indicated that our ES-MGE differentiation protocol generates
MGE-type immature interneurons from J14 ES cells. Previous
study of J14 ES cells showed that they can become cortical
interneurons after transplantation into neonatal brains [32]. We
confirmed this by transplanting sorted D12 Lhx6-GFP+ cells from
our ES-MGE differentiation protocol. Four days after transplan-
tation (4 DAT), about 20% of these Lhx6-GFP+ cells expressed
markers of migrating cortical interneurons including GABA,
Calbindin and MafB (Figure S13A–C in File S3). Thirty to sixty-
nine days after transplantation, the Lhx6-GFP+ cells had a very
low survival rate (,1%), similar to the previous report [32].
Among Lhx6-GFP+ cells that survived at 69 DAT, 22% (mean 6
SEM: 22.3865.01%, n= 4) also expressed Parvalbumin; 58%
(57.96611.50%, n= 3) expressed Somatostatin; and 16%
(15.5166.57%, n= 4) co-expressed Neuropeptide Y (Figure
S13D–G in File S3 and Table S4 in File S2). Our results are
similar to Maroof et al., 2010 [32]. Therefore, the Lhx6-GFP+
cells derived from J14 ES cells have properties of MGE cells based
on gene expression profiling (see above) and have properties of
cortical interneurons based on transplantation analysis.
Novel small enhancers that can be used to enrich MGE-
derived cells
Multiple small DNA enhancer elements that drive expression in
mouse MGE cells have been identified. These include Dlx1 & Dlx2
(Dlx1/2) intergenic enhancer, Dlx5 & Dlx6 (Dlx5/6) intergenic
enhancer, and Lhx6 promoter/enhancers [15,36,37,58]. In addi-
tion, we have been characterizing novel human telencephalic
enhancers, some of which drive expression in MGE cells [59]
(http://enhancer.lbl.gov/). Although none of the enhancers is
entirely specific to MGE cells, their unique expression patterns
may be extremely useful in stem cell studies. Thus, we have
explored their utility in identifying cell types using the ES-MGE
differentiation protocol in mouse E14 and J14 ES cells. We
compared the enhancer activities with markers of MGE cell
identity, including expression of Lhx6-GFP.
We focused on five enhancers that show expression in the
mouse embryonic MGE (Figure 4, seeMaterials and Methods
for genome coordinates and details). Enhancer 422 is located
between human Dlx1 and Dlx2, and includes the Dlx1/2 intergenic
enhancer DlxI12b that drives expression in forebrain GABAergic
neurons, including those derived from the MGE [36]. Similar to
the reported mouse enhancer DlxI12b activity [37], human
enhancer 422 (driving b-Gal expression) was active in MGE
subventricular zone (SVZ) and mantle zones (MZ), as well as in the
LGE/striatum region of E11.5 transgenic mouse brains
(Figure 4A). Enhancer 692 is located on human chromosome
11,500 Kb away from Sox6, a gene that is expressed in the MGE,
its derived neurons, and progenitors of cortical projection neurons
[60,61]. Enhancer 692 drove b-Gal expression in VZ, SVZ, and
MZ of MGE, as well as in migrating neurons of E11.5 transgenic
embryonic brains (Figure 4B). Enhancer 1056 was active only in
the ventral part of the E11.5 MGE VZ and SVZ region
(Figure 4C). The nearest gene from enhancer 1056 is Sal-like 3
(Sall3), at about 250 Kb away. Enhancer 1538 was active in the
VZ, SVZ and MZ of the ventral E11.5 MGE (Figure 4D) and
resides in the vicinity of the Nkx2-1 gene (,70 Kb away). Lhx6
enhancer with proximal promoter (Lhx6 E/P) sits just 59 to the
Lhx6 translational start site and presumably contains an Lhx6
promoter [15]. The Lhx6 E/P is active in regions where
endogenous Nkx2-1 is expressed; it responds to exogenous Nkx2-
1 induction in brain slices and its activities were lost in Nkx2-1-null
brain slices [15].
To determine if these enhancers could be used in labeling
mouse ES cells differentiated toward an MGE fate, we utilized a
lentiviral vector, a-MHC-mCherry_Rex-Blasticidinr, that previ-
ously was used to detect and isolate specific populations of
differentiated ES cells [39]. As mouse DlxI12b enhancer is smaller
than the human enhancer 422 (see Materials and Methods),
and its activities are well documented, we used mouse DlxI12b
instead of 422 for the lentiviral constructs. Three versions of the
lentiviral vector for each enhancer, with different minimal
promoters or none at all, were tested (Figure 4E). Enhancer
activities were evaluated using lentiviruses carrying three different
vectors for DlxI12b & 692 in dissociated primary E13.5 MGE cells.
As shown in Figure S14 in File S3, both enhancer DlxI12b and
enhancer 692 drove mCherry expression in dissociated primary
MGE cells in the absence of an introduced minimal promoter
(Figure S14A and D in File S3; DlxI12b-mCherry and 692-mCherry).
In the presence of the heat shock promoter 68 minimal promoter
(hsp68), both DlxI12b and 692 produced mCherry+ cell clusters;
however, these cells had no 49, 6-diamidino-2-phenylindole
(DAPI) nuclear stains, suggesting cell death (Figure S14B and E
in File S3). The addition of a b-globin minimal promoter (bg)
resulted in stronger mCherry expression driven by DlxI12b, and
increased the number of mCherry+ cells compared to DlxI12b-
mCherry (Figure S14C and A in File S3). By contrast, no obvious
effect was observed from the addition of the b-globin promoter to
the enhancer 692 construct (692-bg-mCherry, Figure S14F in File
S3). We also tested enhancer-less hsp68-mCherry and bg-mCherry
lentiviral constructs in dissociated primary MGE cells. We found
that hsp68 promoter alone drove mCherry expression, whereas b-
globin promoter did not (data not shown). Thus, the b-globin
promoter appeared to be more suitable for our experiments.
We also tested these lentiviruses by infecting MGE-like
differentiated and dissociated mouse ES cells (infected on D11,
and harvested on D14) with the various lentiviral constructs for
DlxI12b and 692, and found results similar to dissociated primary
MGE cells (data not shown).
Enhancer 1056 with or without a b-globin promoter produced
similar numbers of mCherry+ cells in dissociated primary MGE
cells (data not shown). In contrast, enhancer 1538 without a
minimal promoter did not drive mCherry expression in dissociated
primary MGE cells (data not shown).
MGE Enhancers for ES Cells
PLOS ONE | www.plosone.org 10 May 2013 | Volume 8 | Issue 5 | e61956
Enhancer DlxI12b drives mCherry expression in ,30% of
Lhx6-GFP+ mouse ES-derived MGE-like cells
To explore DlxI12b enhancer activities in MGE-like, differen-
tiated mouse ES cells, we generated stable mouse ES clones from
both the E14 and J14 (Lhx6-GFP) cell lines with the DlxI12b-bg-
mCherry_Rex-Blasticidinr lentiviral vector (the Foxg1::venus cell line
is blasticidin-resistant and cannot be used for this purpose). We
analyzed mCherry expression from two independent stable clones
from each cell line (EI12bBM7, EI12bBM8; JI12bBM11,
JI12bBM12). All four clones produced similar numbers of
mCherry+ cells in MGE-like differentiated ES cells (using our
ES-MGE differentiation protocol). We then analyzed the expres-
sion of mCherry along the time course of ES cells differentiation.
We started to detect a few DlxI12b-bg-mCherry+ cells at D9
(Figure 5J). Their number increased substantially on D11 and
D13, but by D15 there was little increase (Figure 5A–C). Double
staining of mCherry with Lhx6-GFP revealed frequent mCherry/
GFP co-expression on D11, D13 and D15 (Figure 5A0–C0). FACS
analyses provided quantification of mCherry/GFP co-expression
and individual protein expression (Figure 5J). The percentage of
Lhx6-GFP+, DlxI12b-bg-mCherry+ and GFP+/mCherry+ cells
was low on D9 and increased from D11. From D11–D15, about
22–30% of the DlxI12b-bg-mCherry+ cells co-expressed Lhx6-
GFP (Figure 5J).
Examining DlxI12b-bg-mCherry expression with markers of
telencephalic cell types showed that 49% of the mCherry+ cells co-
expressed Nkx2-1 on D13, and 55% of the Nkx2-1+ cells co-
expressed mCherry (Figure 5D and Figure S15A-A0 in File S4).
The vast majority of DlxI12b-bg-mCherry+ cells co-expressed
Dlx2 and Calbindin on D11, D13, and D15 (Figure 5E&I; Figure
S15B-B0 and F-F0 in File S4). Some of the DlxI12b-bg-mCherry+
cells also express Foxg1, although to a smaller extent (Figure 5F
and Figure S15C-C0 in File S4), perhaps because DlxI12b-bg-
mCherry expression increased after D9, whereas Foxg1 expression
Figure 4. Expression of MGE enhancers in embryonic forebrains, and lentiviral constructs used to transduce them into primary
MGE cells and ES cells. (A–D): MGE enhancers driving b-galactosidase expression (X-Gal staining) of E11.5 telencephalic sections from transient
transgenic mice. Coronal sections are shown from rostral to caudal (left to right). Each transgene is composed of one enhancer element 422 (A), 692
(B), 1056 (C), or 1538 (D), followed by an hsp68 minimal promoter that drives expression of LacZ (b-galactosidase). (E): Lentiviral constructs harboring
each enhancer reporter cassette for making stable mouse embryonic stem cell clones. Each construct is flanked by a lentiviral 59LTR and a 39LTR, and
contains two separated gene expression cassettes: the first is the enhancer/promotor driving a mCherry reporter gene; the second is Rex-1 promoter
driving the Blasticidin resistant gene (BlaR) [39]. Three lentiviral constructs differed in the first cassette were tested: one without minimal promoter,
one with the heat shock protein 68 (hsp68) minimal promoter, and the last one with the b-globin (bg) minimal promoter. The enhancers tested in this
study were: mouse DlxI12b enhancer (a shorter version of enhancer 422), three novel human enhancers (692, 1056, and 1538), and a mouse Lhx6
proximal enhancer/promoter DNA element [15].
doi:10.1371/journal.pone.0061956.g004
MGE Enhancers for ES Cells
PLOS ONE | www.plosone.org 11 May 2013 | Volume 8 | Issue 5 | e61956
Figure 5. Characterization of DlxI12b-bglobin-mCherry in E14 & J14 ES cells differentiated with ES-MGE protocol. Marker expression
analyses were done with immunofluorescence of sections from aggregates of differentiated ES cells (ES EBs). (A–C): mCherry expression (red) driven
by the DlxI12b-bglobin enhancer/promoter; Lhx6-GFP expression (green) in panels A-A0 (D11 EBs), B-B0 (D13), C-C0 (D15). (D): DlxI12b-bg-mCherry
(red) and Nkx2-1 (green) expression on D13 of differentiation. (E): DlxI12b-bg-mCherry (red) and Dlx2 (green) expression on D13. (F): DlxI12b-bg-
mCherry (red) and Foxg1 (green) expression on D11. (G): DlxI12b-bg-mCherry (red) and Islet1 (green) expression on D13. (H): DlxI12b-bg-mCherry
(red) and Olig2 (green) expression on day 12. (I): Most of the DlxI12b-bg-mCherry+ (red) cells also express Calbindin (green). Scale bar, 100 mm. White
arrows indicate markers co-labeling. (J) FACS analyses of Lhx6-GFP+ cells (on x-axis) and DlxI12b-bg-mCherry+ cells (y-axis) from day 0, day 9, day 11,
day 13 and day 15 of ES-MGE differentiation.
doi:10.1371/journal.pone.0061956.g005
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decreased after D9. None of the DlxI12b-bg-mCherry+ cells
expressed Islet1 or Olig2 (Figure 5G & H; Figure S15D-D0 and E-
E0 in File S4), providing evidence that DlxI12b enhancer was
active in the MGE-derived cortical interneuron progenitors, rather
than LGE (Islet1 is expressed in LGE neurons), or oligodendro-
cytes (Olig2 is an early marker of oligodendrocytes).
Enhancer 692 drives mCherry expression in .70% of
Lhx6-GFP+ mouse ES-derived MGE-like cells
To analyze enhancer 692 activity we attempted to generate
stable ES clones from all three lentiviral vectors (692-mCherry_Rex-
Blasticidinr, 692-hsp68-mCherry_Rex-Blasticidinr, and 692- bg-mCher-
ry_Rex-Blasticidinr). With the 692-mCherry_Rex-Blasticidinr lentivirus,
8 out of the 13 E14 clones (from two different screens) and 6 out of
the 7 J14 clones analyzed contained mCherry+ cells. With the 692-
hsp68-mCherry_Rex-Blasticidinr lentivirus, none of the 6 E14 clones
and none of the only 2 J14 clones analyzed contained mCherry+
cells. With the 692-bg-mCherry_Rex-Blasticidinr lentivirus, 1 out of
the 3 E14 clones and 4 out of 8 J14 clones (from two different
screens) contained mCherry+ cells. The lack of mCherry+ cells in
692-hsp68-mCherry clones may reflect the hsp68-dependent toxicity
we identified in transiently infected MGE cells (Figure S14B and F
in File S3). Thus, we focused on the 692-mCherry and 692-bg-
mCherry clones.
We began by studying the time course of mCherry expression.
Both 692-mCherry and 692-bg-mCherry expression began in a
few cells at D9 in all of the clones examined (Figure 6A; Figure
S16A & E in File S4). By D11, a few more 692-bg-mCherry+ and
692-mCherry+ cells appeared (Figure 6B; Figure S16B, F and I in
File S4). By D13, D15, and D17 there were increasing numbers of
692-mCherry+ and 692-bg-mCherry+ cells (Figure 6C & D; Figure
S16C, D, G, H, and J in File S4).
The emergence of 692-mCherry+ and 692-bg-mCherry+ cells
was positively correlated with the increase of Lhx6-GFP+ cells.
Indeed more than 50% of the Lhx6-GFP+ cells co-localized with
the 692-mCherry+ and 692-bg-mCherry+ cells at all the time
points examined. This was particularly obvious when the fraction
of mCherry+ cells reached its highest on D15 and D17 (Figure 6D–
D0; Figure S17A–C in File S4). Image analyses on three J14 692-
mCherry clones (J6M1, J6M2, and J6M7) on D17 and three J14
692-bg-mCherry clones (J6bM31, J6bM32, J6bM33) on D15
indicated that 692-mCherry and 692-bg-mCherry were present in
similar numbers of cells and the percentages of co-localization
between Lhx6-GFP and mCherry were comparable
(43.28%66.13% of 692-mCherry+ cells were Lhx6-GFP+;
51.04%68.48% of 692-bg-mCherry+ cells were Lhx6-GFP+;
among Lhx6-GFP+ cells, 72.87%65.22% were 692-mCherry+
and 70.08%64.02% were 692- bg-mCherry+).
About 30–50% of 692-mCherry+ and 692-bg-mCherry+ cells
co-expressed Nkx2-1 on D15 and D17; among Nkx2-1+ cells, 63%
were 692-mCherry+ or 692-bg-mCherry+ (white arrows in
Figure 6E; Figure S17A0 in File S4). On the other hand, we did
not detect co-expression of mCherry with Mki67 (Figure 6F;
Figures S16I & J and S17C0 in File S4), suggesting that 692
enhancer was active only in postmitotic cells. Essentially all 692-
mCherry+ cells were Sox6+ (Figure 6G), an MGE marker as well
as a marker for precursors of cortical projection neurons [60,61].
This is interesting considering that enhancer 692 resides near the
Sox6 gene.
Unfortunately, mCherry expression from enhancer 692 was not
robust enough to be seen by mCherry’s intrinsic fluorescence
(Figure 6H); all of our analyses required immunofluoresence.
Thus, we could not use FACS to isolate 692-mCherry+ or 692-bg-
mCherry+ cells.
Enhancer 1056 drives mCherry expression in Olig2+ cells
and not Lhx6-GFP+ cells
Next we made J14 ES cell clones with 1056-bg-mCherry_Rex-
Blasticidinr. From the 4 colonies that we picked and analyzed, just 1
of them expressed mCherry. To our surprise, 1056-bg-mCherry
expression did not co-localize with Lhx6-GFP expression
(Figure 7F & K; Figure S18A-E in File S4). Nor did 1056-bg-
mCherry+ cells express Calbindin or GABA at any of the time
points examined, despite the fact that there were substantial
numbers of mCherry+ cells (Figure 7I and data not shown). Nkx2-
1 was co-expressed in less than 5% of mCherry+ cells (Figure 7G;
Figure S18F-J in File S4). Likewise, very few of 1056-bg-mCherry+
cells co-expressed Islet1+ (Figure 7J).
The MGE generates GABAergic neurons and oligodendrocytes
[11,62]. Thus, we tested whether 1056-bg-mCherry+ cells had
properties of immature oligodendrocytes, by studying Olig2
expression. As shown in Figure 7A–E0, 65–80% of 1056-bg-
mCherry+ cells expressed Olig2. Among Olig2+ cells, 20% of them
were 1056-bg-mCherry+ on day 9 and 56%–70% of them were
1056-bg-mCherry+ on day 11-day 17. In addition, we found 1056-
bg-mCherry/Mki67 double positive cells at all of time points
examined (white arrows in Figure 7H and in Figure S18K-O in
File S4 on D9–D17). This suggested some of the 1056 enhancer-
labeled cells continued to divide at late time points of differen-
tiation.
Interestingly, 1056-bg-mCherry+ (as well as Olig2+) cells
appeared randomly distributed inside the EB aggregates, whereas
Lhx6-GFP+ cells and Nkx2-1+ cells were usually clustered at the
outer surface of the EB aggregate. Consistent with 1056’s selective
activity in Olig2+ cells, FACS analyses of the 1056-bg-mCherry
J14 clone showed that Lhx6-GFP+ cells did not overlap with the
1056-bg-mCherry+ cells population from D9–D17 (Figure 7K).
Enhancer 1538 drives mCherry expression in .40% of
Lhx6-GFP+ mouse ES-derived MGE-like cells
To test enhancer 1538 activity, we generated J14 stable ES lines
with 1538-bg-mCherry_Rex-Blasticidinr. We analyzed 5 clones; 2 of
the clones had mCherry expression starting at D12 (Figure 8A &
B). There were almost no mCherry+ cells on D10 (Figure 8A). On
D12–D14, many 1538-bg-mCherry+ cells appeared (Figure 8B &
C). Though 1538 enhancer resides in close proximity to Nkx2-1
gene locus, its activity in the differentiating ES cells did not fully
correlate with that of Nkx2-1 expression (Figure 8E; Figure S19A–
D in File S4): endogenous Nkx2-1 expression appeared early at D9
(Figure S10 in File S1) whereas 1538-driven mCherry expression
was not detected at D10, but was found later on D12 (Figure 8A &
B). There were more Nkx2-1+ cells than 1538-bg-mCherry+ cells
(Figure 8E; Figure S19A–D in File S4); nevertheless, all of the
1538-bg-mCherry+ cells appeared to be Nkx2-1+. A few cells with
enhancer 1538 activity expressed MKi67+, suggesting that they
were mitotically active (arrows in Figure 8F; Figure S19E–H in
File S4). 1538-driven mCherry expression was highly correlated
with Lhx6-GFP expression (Figure 8B0–D0). We analyzed the
Lhx6-GFP+ and mCherry+ cells on D14: 40% (41.18%64.32%) of
Lhx6-GFP+ cells were mCherry+; 90% (92.26%63.78%) of
mCherry+ cells were Lhx6-GFP+. 1538 driven mCherry expres-
sion was too low for FACS detection (Figure 8G); therefore our
analyses required mCherry detection by immunofluoresence.
No mCherry expression was detected with Lhx6
enhancer/promoter constructs
We also generated a lentiviral vector with a putative Lhx6
promoter/enhancer DNA fragment (Lhx6 E/P-mCherry_Rex-blas-
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ticidinr) hoping that it could substitute Lhx6-GFP BAC’s activities.
Unfortunately despite the fact that it was active in dissociated
MGE cells (Figure S14G in File S3), we did not see any mCherry+
cells from MGE-like differentiated ES cells in any of the 7 stable
J14 ES clones infected with this construct.
The DlxI12b enhancer continued to be active in the adult
cortex
While our work focused on the activity of the enhancers in
MGE-like differentiated ES cells in vitro, we explored whether the
Figure 6. Enhancer 692-bg-mCherry was active in 70% of Lhx6 GFP+ cells. (A–D0): mCherry expression (red) driven by 692-bg and Lhx6-GFP
(green) expression on D9 (A-A0), D11 (B-B0), D13(C-C0), and D15 (D-D0) ES EB aggregates. On D13 and D15, about 70% of the 692-mCherry+ cells
were labeled with Lhx6-GFP (white arrows). (E): 692-bg-mCherry (red) and Nkx2-1 (green) expression on D15. (F): 692-bg-mCherry+ (red) cells are
postmitotic, as they don’t express Mki67 (green) on D15 (and other earlier time points). (G): E14 cells line carrying 692-mCherry was examined with
Sox6 expression. All of the 692-mCherry+ (red) cells express Sox6 (green). White arrows indicate markers co-labeling. Scale bar, 100 mm. (H) FACS
analyses of Lhx6-GFP+ cells (on x-axis) and 692-mCherry+ cells (y-axis) from day 0, day 9, day 11, day 13 and day 16 of ES-MGE differentiation. Though
692-mCherry+ (and 692-bg-mCherry+) cells was detected with immunostaining and showed extensive co-localization with Lhx6-GFP signals, their
endogenous intensity was too low to be detected by FACS (no staining was done with FACS analyses).
doi:10.1371/journal.pone.0061956.g006
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DlxI12b and 692 enhancers maintained their expression in vivo
following transplantation into neonatal mouse cortex. We used
FACS to purify GFP+ cells from differentiated (D12) J14 ES cells
that also carried either enhancer DlxI12b [line: DlxI12b-bg-
mCherry (JI12bbM11)] or 692: [line: 692-mCherry (J6M1)]. As
described above, in vitro (on D12) 30% of these Lhx6-GFP+ cells
are DlxI12b-bg-mCherry+ (for JI12bbM11), and 70% of the Lhx6-
GFP+ cells are 692-mCherry+ (for J6M1).
Analyses of seven transplants from JI12bbM11 [4 animals from
69 DAT, and 3 animals from 33 DAT] found 28.3362.81%
(mean 6 SEM, n= 7) of Lhx6-GFP+ cells were DlxI12b-bg-
mCherry+ (Figure S20A–B0 in File S5), showing that the DlxI12b
enhancer continued to be active in the adult cortex. On the other
hand, we had difficulty finding 692-mCherry+/Lhx6-GFP+ cells in
4 transplants from J6M1 (33 DAT) suggesting that either enhancer
692 is not active, or had low activity, in mature neurons (data not
shown). Thus, enhancer DlxI12b, but not 692, is effective for
labeling ES cell-derived MGE-derived mature neurons in the adult
cortex.
Discussion
MGE-derived interneuron progenitors have tremendous poten-
tial for regenerative medicine [24,26,63]. Towards this end, we
explored methods to generate and purify these MGE-like
interneuron progenitors.
Figure 7. Characterization of 1056-bg-mCherry in J14 ES cells differentiated with ES-MGE protocol. Enhancer 1056-bg-mCherry+ cells are
Olig2+ and don’t express markers of MGE-derived neurons. (A–E0): mCherry expression (red) driven by the 1056-bg and Olig2 (green) expression are
shown in panels A-A0 (D9 aggregates), B-B0 (D11), C-C0 (D13), D-D0 (D15) and E-E0 (D17). Almost all of the 1056-bg-mCherry+ cells express Olig2
(white arrows) on all the time points examined. Only a few 1056-bg-mCherry+ cells are Olig22 (white arrowheads in B-B0 and C-C0). (F): 1056-bg-
mCherry (red) and Lhx6-GFP (green) expression on D11. (G):, 1056-bg-mCherry (red) and Nkx2-1 (green) expression on D11. Some of the Nkx2-1+ cells
are also 1056-bg-mCherry+. (H): A few 1056-bg-mCherry (red)+ cells are still mitotically active, as indicated by Mki67+ (green) staining on D11. (I):
1056-bg-mCherry (red) and Calbindin (green) expression on D11. (J): 1056-bg-mCherry (red) and Islet1 (green) expression on D11. White arrows
indicate co-labeling of respective markers shown. Scale bar for all panels, 100 mm. (K) FACS analyses of Lhx6-GFP+ cells (on x-axis) and 1056-bg-
mCherry+ cells (y-axis) from day 0, day 9, day 11, day 13, day 15 and day 17 of ES-MGE differentiation. There was no detectable GFP/mCherry double
positive cell.
doi:10.1371/journal.pone.0061956.g007
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Generation of MGE-like Cells in vitro
Our approach to expand MGE-derived neurons in vitro from
dissociated primary cells failed. We found that while MGE cells
became Dlx2+ GABAergic neurons, they lost Lhx6-GFP expres-
sion, highlighting the need to identify factors necessary to maintain
Lhx6 expression. In contrast, methods to differentiate ES cells into
MGE-like progenitors and neurons have been evolving
[31,32,33,34]. Using a modified SFEBq protocol (ES-MGE) we
improved the efficiency (about 2-fold increase; Fig. S2A9 in File
S1) of inducing Lhx6-GFP+ cells compared to that of Danjo et al.,
2011.
Figure 8. Enhancer 1538-bg-mCherry+ labeled 40% of Lhx6-GFP+ cells. (A–D0): mCherry expression (red) driven by 1538-bg and Lhx6-GFP
(green) expression in panels A-A0 (D10 aggregates), B-B0 (D12), C-C0 (D14), and D-D0 (D16). On D14, 40% of Lhx6-GFP+ cells are 1538-mCherry+ and
more than 90% of the 1538-bg-mCherry+ cells were also labeled with Lhx6-GFP (white arrows). (E): 1538-bg-mCherry (red) and Nkx2-1 (green)
expression on D14. (F): Most of the 1538-bg-mCherry (red)+ cells were postmitotic, as they don’t express Mki67 (green) on D14 (and other earlier time
points). There were a few exceptions (white arrows). Scale bar, 100 mm. (G) FACS analyses of Lhx6-GFP+ cells (on x-axis) and 1538-bg-mCherry+ cells
(y-axis) from day 0, day 8, day 10, day 12, day 14 and day 16 of ES-MGE differentiation. Similar to the enhancer 692, the mCherry expression activity of
enhancer 1538 appeared too low to be detected by FACS (no staining was done with FACS analyses).
doi:10.1371/journal.pone.0061956.g008
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Our ES-MGE differentiation protocol generated progenitors
and neurons with MGE-like molecular properties. At D12, cell
clusters within the ES aggregates (EBs) expressed markers of
immature MGE-derived neurons (Nkx2-1+/Lhx6+) (Figure 2B0).
While many cells did not express MGE markers, they lacked
detectable expression of pallial markers (Tbr1 and Pax6) (Figure 2J;
Table S2 in File S2). The Nkx2-12/Lhx62 regions may contain
LGE/striatal cells (Islet1+ and CTIP2+ expression, Figure 2H and
data not shown), but neither marker is LGE-specific. Olig2+ cells
contributed to some of the Nkx2-12/Lhx6-GFP2 cells (Figure 2K;
Figures S9, and S11 in File S1), and probably correspond to
immature oligodendrocytes. Therefore, our ES-MGE differentia-
tion protocol, while relatively specific for MGE specification, is not
highly efficient.
The Nkx2-1+ MGE-like domains within the EBs appeared
around D8–9, similar to previous reports [31,34]. More than 50%
of these Nkx2-1+ cells were proliferating at D9 based on Mki67
expression (Figure S10 in File S1). From D10 to D12, there was an
increase of Nkx2-1+/Lhx6+ cells (Figure 2B–C0); this expansion of
the ‘‘MGE’’ clusters from D9–D13 suggested that Nkx2-1+ cells
continued to divide. Later at D14–D16, the EBs expressed makers
of immature MGE-derived neurons (Lhx6, GABA and Calbindin;
Figure 2D9 and Figure S3 in File S1). Furthermore, transplanta-
tion of FAC-sorted Lhx6-GFP+ cells generated neurons that
expressed markers of mature interneurons (Figure S13D–F0 in File
S3) as reported by Maroof et al., 2010.
Comprehensive gene expression analysis showed that partial
RNA profiles of ES-derived Lhx6-GFP+ cells (at D12 of
differentiation) were similar to E12.5 mouse Lhx6-GFP+ MGE
cells: both types of Lhx6-GFP+ cells resembled immature MGE-
derived interneurons, and lacked prominent expression of markers
of other MGE-derived cells such as oligodendrocytes (Table 1;
Table S2 & S3 in File S2).
Since the ES-Lhx6-GFP+ cells expressed Nkx2-1 and Lhx8
RNAs (Table 1), they probably correspond to cells that can
differentiate into several lineages of MGE-derived neurons,
including pallial interneurons, striatal interneurons and the globus
pallidus neurons [49,64,65]. However, the gene expression array
data showed lower expression of markers of globus pallidus
neurons (e.g. ER81; Table 1; Table S2 in File S2); therefore, we
postulate that the ES-Lhx6-GFP+ cells are most similar to bi-
potential (pallial and striatal) immature interneurons. Further-
more, we suggest that these cells do not differentiate into subpallial
cholinergic neurons because they have low expression of Islet1 and
Gbx2 [65,66,67] based on immunofluorescence (Figure 2H) and
array data (Table S2 in File S2). Finally, we found higher
expression of MGE-derived cortical interneuron markers MafB
and cMaf (Table 1; [57]) in the ES-Lhx6-GFP+ cells, providing
evidence that they are biased towards pallial vs. striatal
GABAergic interneurons.
We showed that ES-Lhx6-GFP+ cells transplantation into
neonatal mouse produced cortical interneurons (Figure S13 in
File S3). We did not test striatal transplantation; it is possible that
these cells would produce some striatal interneurons, as found for
MGE transplantation [28]. Future studies are needed to establish
methods to promote pallial interneuron differentiation from these
bi-potential progenitors. For instance, we have evidence that
Zfhx1b transcription factor participates in the switch between
pallial and striatal interneuron identity [57]. Zfhx1b was expressed
3-fold higher in MGE-Lhx6-GFP+ cells than the ES-Lhx6-GFP+
cells (Table S2 in File S2); perhaps increased Zfhx1b function
would repress Nkx2-1 and Lhx8, and potentiate the differentiation
of pallial interneurons.
Use of ‘‘MGE Enhancers’’ to monitor MGE cell
differentiation
The use of molecular markers of specific cell states is a powerful
tool for studying cell differentiation. In particular, expression of
fluorescent proteins, from specific endogenous gene loci, or from
transgenes (e.g. BACs), is an effective method to identify and purify
cells. Two published ES cell lines mark MGE differentiation: 1)
mouse J14 ES cells that express GFP from an Lhx6 BAC [32]; 2)
human ES cells that express GFP from the Nkx2-1 locus [33]. Our
alternative approach, driving reporter expression using cell/tissue-
specific promoters and/or small enhancer elements [39], has
several potential advantages: 1) the small size of the enhancers,
often less than 1 kb, makes them ideal for insertion into viral
vectors; 2) the small enhancers often have a more restricted range
of tissue and cell type expression; 3) the approach is ideal for
marking multiple cell lines, which would be extremely difficult
using BAC transgenic or knock-in strategies; 4) knock-in strategies
can alter gene function.
We have identified a large number of enhancer elements in the
human genome that drive expression in specific subdivisions of the
E11.5 mouse telencephalon, including the MGE [68] (see http://
enhancer.lbl.gov/). We explored the function of three of these
(novel enhancers 692, 1056, and 1538), in addition to the mouse
DlxI12b and Lhx6 promoter/enhancers [15,36,37]. We introduced
each of these five enhancers into the E14 and J14 mouse ES cells
[32] using the vector described by Kita-Matsuo et al., (2009),
subjected them to the ES-MGE differentiation protocol, and
analyzed mCherry expression in EBs. Four of the enhancers drove
mCherry expression in MGE-like cells; only the Lhx6 enhancer did
not work. Enhancer 1056 drove expression in Olig2+/Lhx6-GFP2
cells (Figure 7). As the MGE also generates oligodendrocytes
[11,62], we predict that enhancer 1056 will be useful for driving
expression in oligodendrocyte progenitors. A subset of enhancer
1056+ cells also expressed Nkx2-1 (Figure 7G); these may be
progenitors capable of generating MGE-type neurons, as Olig2 is
co-expressed with Nkx2-1 in the ventricular zone of the E11.5
MGE (Figure S21 in File S5; also see Figure S11 in File S1 for
differentiated ES data).
Enhancers DlxI12b, 692, and 1538 drove mCherry expression in
MGE-like neurons (Nkx2-1+/Lhx6-GFP+), but not Olig2+ cells
(Figure 5, 6 & 8). Given that ES-Lhx6-GFP+ cells have properties
of immature pallial interneurons, based on gene expression array
analysis (Table 1 and Table S2 in File S2) and in transplantation
assays (Figure S13 in File S3; [32]), we propose that DlxI12b, 692,
and 1538 drive expression in cells with properties of MGE-derived
interneurons.
DlxI12b enhancer was active in both immature and mature
pallial interneurons (Figure S20 in File S5), whereas enhancer 692
appeared to be active only in immature MGE cells (data not
shown). Furthermore, it will be of interest to follow the fate of
enhancer 1056 marked cells (1056-bg-mCherry+ cells) following
cortical transplantation to determine whether they develop into
mature oligodendrocytes [62].
The survival rate of FACS sorted cells followed by cortical
transplantation was ,1% (similar to Maroof et al., 2010[32]).
Because we suspect that FACS cell sorting contributes to the low
viability, it will be beneficial to pursue other methods for cell
purification, including magnetic bead-conjugated antibodies, and
the use of enhancer-driven drug selectable markers.
Overall, comparing enhancer activities in transgenic mice and
in differentiated mouse ES cells (Table S5 in File S2), only
enhancer DlxI12b faithfully conveys its activity from in vivo to in
vitro. It is not active in VZ and SVZ (cells from VZ and SVZ are
actively dividing) of embryonic MGE in transgenic mice
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(Figure 4A), nor in mitotically active mKi67+ differentiated ES
cells (data not shown). It is active in MZ (cells from MZ are mostly
postmitotic cells) of embryonic MGE in transgenic mice
(Figure 4A) and is active in mKi672 differentiated ES cells (data
not shown). In transgenic mice three of the enhancers (692, 1056,
and 1538) are active in the VZ and SVZ of embryonic MGE
(Figure 4B–D); however only two of the enhancers have some
activity in mitotically active differentiated ES cells (i.e. 1056 and
1538) (Figure 7H and 8F). Enhancer 1056 is active in VZ and SVZ
of MGE, but it is not active in MZ of MGE in transgenic embryos
(Figure 4C). In contrast, about 5% of 1056-mCherry+ cells are
mitotically active in differentiated ES cells in vitro (Figure S18K-O
in File S4). We hypothesize that as 1056-mCherry+ cells mature,
they turn off Nkx2-1 and differentiate along the oligodendrocyte
lineage.
It will be helpful to identify an ‘‘MGE enhancer’’ that more
effectively drives expression in dividing cells, to enable selection
with a drug-resistance gene. This would greatly facilitate
generating large numbers of homogeneous MGE interneuron
progenitors for further study and, ultimately, for transplantation in
diseased states.
Our approach of using highly specific small enhancers has
general utility for generating diverse types of CNS cells. For
instance, we have identified enhancers for the LGE and pallium,
including its regional subdivisions [68] (see http://enhancer.lbl.
gov/) that can be used for selecting these types of progenitors and
their derivatives. Introducing these enhancer constructs into ES
and iPS cells may facilitate identification and isolation of many
different neural cell lineages for basic and translational studies.
Supporting Information
File S1 Text T1, Method M1 & M2, Figure S1–S11. Text
T1: Dissociated MGE cells grown in vitro lose Lhx6-GFP
expression. Method M1: MGE primary culture and antibodies
for immunofluorescent studies. Method M2: Transient lentiviral
infection in primary MGE and dissociated/differentiated ES cells.
Figure S1: Primary MGE cells in vitro differentiate into Dlx2+
GABAergic neurons, but lose Lhx6 expression. A–D’’, E13.5 MGE
(ventricular and subventricular zone of the MGE) from Dlx5/6-
LacZ+ embryos was removed from the telencephalon, dissociated
and cultured in vitro using the media as described (Walton et al.,
2006). Ten days after growing in the proliferation media (10
DIVpro), the cells were differentiated using differentiation media
(DIVdiff). The state of differentiation was compared during
proliferation (A-A0 and C-C0) or after 4 days of differentiation (B-
B0 and D-D0) by immunostaining with antibodies to b-Galactosi-
dase (b-Gal), GAD1 (GAD67), Dlx2 and Class III b-Tubulin
(Tuj1). Scale bar, 100 mm. E–K, Lhx6-GFP expression in cells
derived from E12.5 MGE (ventricular and subventricular zone of
the MGE). The Lhx6-GFP+ MGEs were dissociated and cultured
in vitro. Top row: MGE cells grown in proliferation media for 3 (E),
7 (F), 10 (G) and 13 (H) days. Cells were passaged by trypsinization
and expansion onto bigger culture dishes on day 7. Bottom row:
MGE cells cultured in proliferation media for seven days and then
in differentiation media for 0 (I), 3 (J), and 6 (K) days. Images are
overlay of DIC images and green fluorescent images. Scale bar,
150 mm. Figure S2: Comparison of various conditions for mouse
ES cells differentiation. (A and A9): J14 was subjected to three
different conditions for differentiation (the schematic was the same
as shown in main figure 2 A) as shown. On D12 and D15, cells
were analyzed by FACS analyses to determine the percentage of
Lhx6-GFP+ cells. Both condition 1 (ES-MGE differentiation
protocol, our current protocol, shown in blue) and condition 2
(MGE-type cells protocol, shown in red, (Danjo et al., 2011))
included Shh pathway activators and promoted MGE-like
progenitor cells. Condition 3 (cortical cell protocol, in grey,
(Eiraku et al., 2008): addition of Dkk-1, without Shh or SAG)
generated very few Lhx6-GFP+ cells from J14 cell line. (A9):
Compared to condition 2 and 3, condition 1 produced the most of
Lhx6-GFP+ cells on D12 and D15 of differentiation. (B and B9):
Four conditions were used to differentiate JI12bBM11 cell line
(J14 carrying DlxI12b-bg-mCherry). In Condition 1 (shown in blue)
6 nM SAG was applied while in condition 2 (in green) 2 mM
purmophamine was used to promote MGE-like progenitor cells.
In condition 3 (in purple), 1 mg/ml Dkk-1 was added on D0, in
compared to 100 ng/ml Dkk-1 in condition 1 and 2. In condition
4 (shown in red), additional growth factors and small molecule
(BMPR1A and SB431542) was added on day 0. (B9): Much more
purmophamine is required (2 mM) (Condition 2) to reach the same
efficiency generated by SAG (6 nM) (Condition 1). Ten times
more Dkk-1 (1 mg/ml) (Condition 3) only produced slightly more
Lhx6-GFP+ cells on D12 but not on D14. Addition of activin/
nodal inhibitor SB431542 and BMP activator BMPR1A on D0
(Condition 4) diminished the effects of 1 mg/ml Dkk-1 on Lhx6-
GFP+ cells production. (C, C9 and C0): Foxg1::venus and
JI12bBM11 (J14 carrying lentiviral enhancer DlxI12b-bg-
mCherry) were tested for differentiation using four conditions
listed (as shown in Figure 1). In condition 1 and 2 (shown in blue
and green), cells were differentiated in GMEM+10% KSR media
while in condition 3 and 4 (shown in red and purple), cells were
differentiated in Neurobasal media supplemented with B27
without retinoic acid (NB/B27), a commonly used media for
neural progenitor differentiation (Turksen and Troy, 2006). Either
100 or 200 ng/ml Dkk-1 was added on D0. For all three cell lines
tested (including J6M1 in Figure 1), KSR-containing media
surpassed NB/B27 media in the generation of Foxg1::venus+ cells
or Lhx6-GFP+ cells. Addition of 26more Dkk-1 on D0 did not
improve the efficiency of Lhx6-GFP+ cells or Foxg1::venus+
production with KSR media. Figure S3: Characterization of
differentiated E14 cells. Expression of Nkx2-1 (red in all panels)
with other markers (shown in green): Mash1 (A, A9), Islet1 (B, B9),
GABA (C, C9), and Calbindin (D, D9), in E14 cell line on D9 and
D15 after differentiation. DAPI nucleus staining was shown in blue
in all panels. There are more Mash1+ cells than Nkx2-1+ cells (and
some of them express both proteins) on D9. On D15, both protein
expressions are reduced with more Nkx2-1+ cells than Mash1+
cells. Scale bar: 100 mm. Figure S4: Expression of Lhx6-GFP and
Dlx2 in J14 cells. J14 cells were differentiated with our ES-MGE
protocol. On day 10 (D10; A, A9, A0), D12 (B, B9, B0), D14 (C, C9,
C0) and D16 (D, D9, D0), cell aggregates were collected for
analyses by immunofluorescent staining for Dlx2 (red) and GFP
(green). Similar to Lhx6-GFP+ cells, the number of Dlx2+ cells
peaked on D12–14. Arrows indicate co-localization of Dlx2 and
Lhx6-GFP. Scale bar, 100 mm. Figure S5: Expression of Lhx6-
GFP and Foxg1 in J14 cells. J14 cells were differentiated with our
ES-MGE protocol. Expression of Foxg1 (red) and Lhx6-GFP
(green) were examined from cell aggregates collected on D10 (A,
A9, A0), D12 (B, B9, B0), D14 (C, C9, C0) and D16 (D, D9, D0). The
expression of Foxg1 was highest at D10–D12 of differentiation and
went down at D14–D16. Scale bar, 100 mm. Figure S6:
Expression of Lhx6-GFP and Islet1 in J14 cells. J14 cells were
differentiated with our ES-MGE protocol. On D9 (A, A9, A0), D11
(B, B9, B0), D13 (C, C9, C0) and D15 (D, D9, D0), cell aggregates
were collected for analyses by immunofluorescent staining: Islet1
(red) and GFP (green). Note the random distribution of Islet+ cells
within the aggregates compared to the clustered Lhx6-GFP+ cells.
Scale bar, 100 mm. Figure S7: Expression of Lhx6-GFP and
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Mki67 in J14 cells. J14 cells were differentiated with our ES-MGE
protocol. On D9 (A, A9, A0), D11 (B, B9, B0), D13 (C, C9, C0) and
D15 (D, D9, D0), cell aggregates were collected for analyses by
immunofluorescent staining: Mki67 (red) and GFP (green). All of
the Lhx6-GFP+ cells were postmitotic. Scale bar, 100 mm. Figure
S8: Expression of Lhx6-GFP and Tbr1 in J14 cells. J14 cells were
differentiated with our ES-MGE protocol. On D10 (A, A9, A0),
D12 (B, B9, B0), D14 (C, C9, C0) and D16 (D, D9, D0), cell
aggregates were collected for analysesby immunofluorescent
staining: Tbr1 (red) and GFP (green). There was no Tbr1+ cell
in any time point examined. Scale bar, 200 mm. Figure S9:
Expression of Lhx6-GFP and Olig2 in J14 cells. J14 cells were
differentiated with our ES-MGE protocol. On D10 (A, A9, A0),
D12 (B, B9, B0), D14 (C, C9, C0) and D16 (D, D9, D0), cell
aggregates were collected for analyses by immunofluorescent
staining: Olig2 (red) and GFP (green). Similar to Lhx6-GFP+ cells,
the number of Olig2+ cells peaked on D12–14. All of the Lhx6-
GFP+ cells were Olig22. Scale bar, 100 mm. Figure S10:
Expression of Nkx2-1 and Mki67 in J14 cells. J14 cells were
differentiated with our ES-MGE protocol. On D9 (A, A9, A0), D11
(B, B9, B0), D13 (C, C9, C0) and D15 (D, D9, D0), cell aggregates
were collected for analyses by immunofluorescent staining: Mki67
(red) and Nkx2-1 (green). Plenty of Mki67+ cells were present and
co-labeled with Nkx2-1 on day 9 and the number of Ki67+ cells
went down on subsequent time points. There were significantly
lower Nkx2-1+ that were also Mki67+ on D11 and D13. Scale bar,
100 mm. Figure S11: Expression of Nkx2-1 and Olig2 in J14 cells.
J14 cells were differentiated with our ES-MGE protocol. On D10
(A, A9, A0), D12 (B, B9, B0), D14 (C, C9, C0) and D16 (D, D9, D0),
cell aggregates were collected for analyses by immunofluorescent
staining: Nkx2-1(red) and Olig2 (green). About 5% of Olig2+ cells
co-labeled with Nkx2-1 on D9 and the number of Nkx2-1+/Olig2+
(double positive) cells decreased on subsequent time points. Scale
bar, 100 mm.
(PDF)
File S2 Table S1–S10. Table S1: Abbreviated Names. Table
S2: Select marker genes expression from differentiated ES cells (ES
Lhx6-GFP+ and ES Lhx6-GFP2) and E12.5 MGE cells (MGE
Lhx6-GFP+) and the comparisons (fold change) of ES Lhx6-GFP+
vs. ES Lhx6-GFP2, MGE Lhx6-GFP+ vs. ES Lhx6-GFP2, and
MGE Lhx6-GFP+ vs. ES Lhx6-GFP+. Column 1 lists marker
genes for specific cell types and regions. Note that many of these
are not specific for those cells states, but are recognized as useful
markers. The expression levels in the columns 2–4 represent the
averaged normalized log2 intensity for each gene. The numbers in
columns 5–7 (the fold change) are ratios of the average signal
intensity (unlogged) of the two groups in comparison. Red colored
genes are enriched in ES Lhx6-GFP2 cells whereas green colored
genes are enriched in both MGE Lhx6-GFP+ and ES Lhx6-GFP+
cells. For most of the genes, the expression in the ES Lhx6-GFP+
cells and MGE Lhx6-GFP+ cells show similar expression trends, in
comparison to ES Lhx6-GFP2 cells. However, there are a few
genes (shown in black) that don’t follow this trend. Table S3: Block
A and Block B from the supervised clustering map (Figure 3).
Genes from block A and B of the supervised heatmap (Figure 3)
are list below (the order of the genes are the same as in the map
(from top to bottom). Many of the genes that regulate and/or
mark developing cortical interneurons as shown in Tables 1 and
S2 are bold-typed. Table S4: Cell counts from 69 days after
transplantation. Four transplants (mice that received Lhx6-GFP+
cells and had at least 10 Lhx6-GFP+ cells in the cortex: N1, R3,
R5 and R6) were examined for co-labeling of Lhx6-GFP with
parvalbumin (PV), somatostatin (SOM), and neuropeptide Y
(NPY). Total numbers, average, and standard errors from 3–4
transplants were shown. Table S5: Comparison of enhancer
activities in transgenic embryos and differentiated ES cells. Table
S6: Differentially expressed (Fold change are.=4) genes between
ES Lhx6-GFP+ vs ES Lhx6-GFP- cells. Table S7: Differentially
expressed (Fold change are .=4) genes between MGE Lhx6-
GFP+ vs ES Lhx6-GFP+ cells. Table S8: Differentially expressed
(Fold change are .=4) genes between MGE Lhx6-GFP+ vs ES
Lhx6-GFP- cells. Table S9: Supervised heatmap genes (1821
probes). Table S10: Primer sequences used for lentiviral construct.
(PDF)
File S3 Figure S12–S14. Figure S12: Unsupervised clustering
showing 1000 most variable probes.Microarray comparison of
RNA expression from primary E12.5 MGE Lhx6-GFP+ cells, ES-
Lhx6-GFP+ and ES-Lhx6-GFP2 cells. Show here are 1000 most
variable probes. Figure S13: Transplanted Lhx6-GFP+ cells
express cortical interneuron markers in the cortex. (A–C) Four
days after transplantation, some of the Lhx6-GFP+ cells were also
GABA+ (A), Calbindin+ (B), or MafB+ (C). White arrows indicate
double positive cells. (D–F’’) Sixty-nine days after transplantation,
Lhx6-GFP+ cells expressed parvalbumin (PV) (D, D9, D0),
somatostatin (SST) (E, E9, E0) and neuropeptide Y (NPY) (F, F9,
F0). Arrows indicate markers co-labeling. In PV/GFP co-staining,
there were some GFP+ cells that have weak PV expression (white
arrowheads). Scale bar, 100 mm. (G) Average (data are mean 6
SEM) percentages of parvalbumin+ (PV+/GFP+), somatostain+
(SST+/GFP+), neuropeptide Y+ (NPY+/GFP+) cells among all
Lhx6-GFP+ cells (n = 3–4). Figure S14: Test of lentiviral constructs
in dissociated primary MGE cells. Dissociated primary MGE cells
(E13.5) were infected with each of the lentiviruses indicated (A:
DlxI12b-mCherry, B: DlxI12b-hsp68-mCherry, C: DlxI12b-bg-mCherry,
D:692-mCherry, E: 692-hsp68-mCherry, F:692-bg-mCherry, G: Lhx6-
E/P-mCherry) for three days before being fixed for immunostaining.
Pictures are composites from several different fields (A–F) or from
one single field (G). Shown here are Nkx2-1 staining in green,
mCherry in red, and DAPI nuclear stain in blue. Scale bar,
50 mm.
(PDF)
File S4 Figure S15–S19. Figure S15: Additional characteriza-
tion of the enhancer DlxI12b. Mouse ES cell lines E14 (B-B0 & E-
E0) and J14 (A-A0, C-D0 & F-F0) carrying enhancer DlxI12b-bg-
mCherry were differentiated with our ES-MGE protocol. Expres-
sion of DlxI12b-bg-mCherry (red) was examined on D11, D13,
and D15 together with other markers (shown in green): (A) Nkx2-
1, (B) Dlx2, (C) Foxg1, (D) Islet1, (E) Olig2, (F) Calbindin. Scale
bar, 200 mm. Figure S16: Additional characterization of the
enhancer 692. (A–D) Mouse ES cell lines J14 carrying enhancer
692-bg-mCherry were differentiated with our ES-MGE protocol.
Expression of 692-bg-mCherry (red) was examined together with
Nkx2-1 (shown in green) on D9, D11, D13, and D15. Scale bar,
200 mm. (E–J) Mouse ES cell lines E14 carrying 692-mCherry were
differentiated with our current MGE protocol. Expression of 692-
mCherry (red) was examined with Nkx2-1 (E–H) and Mki67 (I, J)
(shown in green) on days indicated. Scale bar, 100 mm. White
arrows indicate co-labeling of respective markers shown. Figure
S17: Additional characterization of the enhancer 692. Mouse ES
cell lines J14 carrying enhancer 692-mCherry were differentiated
with our ES-MGE protocol. Expression of 692-mCherry (red) was
examined on D17 together with other markers (shown in green):
(A) Nkx2-1, (B) Lhx6-GFP, (C) Mki67. White arrows indicate co-
labeling of respective markers shown. Scale bar, 100 mm. Figure
S18: Additional characterization of the enhancer 1056. Mouse ES
cell line J14 carrying enhancer 1056-bg-mCherry were differentiated
with our ES-MGE protocol. Expression of 1056-bg-mCherry (red)
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was examined on D9, 11, 13, 15 and 17 together with other
markers (shown in green): (A–E) Lhx6-GFP, (F–J) Nkx2-1, (K-O)
Mki67. Scale bar, 100 mm. Figure S19: Additional characteriza-
tion of the enhancer 1538. Mouse ES cell line J14 carrying
enhancer 1538-bg-mCherry were differentiated with our ES-MGE
protocol. Expression of 1538-bg-mCherry (red) was examined on
D10, 12, 14 and 16 together with other markers (shown in green):
(A–D) Nkx2-1, (E–H) Mki67. Scale bar, 100 mm.
(PDF)
File S5 Figure S20–S21. Figure S20: All of the DlxI12b-bg-
mCherry+ cells express Lhx6-GFP thirty-three days after trans-
plantation into the neocortex (white arrows in A-A0). About 28%
of Lhx6-GFP+ cells are also DlxI12b-mCherry+. One of the double
positive cells (DlxI12b-bg-mCherry+, Lhx6-GFP+) is shown in B-
B0. Scale bar for A-A0: 200 mm; for B-B0: 50 mm. Figure S21:
Expression and colocalization of Olig2 and Nkx2-1 in the
progenitor zones of the embryonic MGE. E11.5 coronal section
through mouse forebrain showing Nkx2-1 (red), Olig2 (green), and
DAPI (blue) as visualized by indirect immunofluorescence at the
level of the MGE and LGE. At the ventricular zone and
subventricular zone of the MGE, all of the cells are labeled by
both Nkx2-1 and Olig2 (as shown by double labeling on the lower
right panel). The images were taken at a Zeiss Confocal
Microscope LSM 510 NLO Meta. Scale bar, 50 mm.
(PDF)
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